EP1968612
Tvíkirnisforlyf
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
13.12.2006EP published:
9.3.2016EP application number:
06848625.7
EP translation filed:
6.4.2016Grant published:
15.4.2016EPO information:
European Patent Register
Max expiry date:
12.12.2026Expiry date:
12.12.2020
Title:
DINUCLEOTIDE PRODRUGS
Timeline
Today
13.12.2006EP application
9.3.2016EP Publication
6.4.2016Translation submitted
15.4.2016Registration published
12.12.2020Expires
Owner
Name:
Spring Bank Pharmaceuticals, Inc.Address:
113 Cedar Street, Suite S-7, 01757, Milford, MA, US
Inventor
Name:
IYER, Radhakrishnan, P.Address:
Shrewsbury, MA, US
Name:
PADMANABHAN, SeetharamaiyerAddress:
Lexington, MA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
750036 PDate:
13.12.2005Country:
US
Number:
800294 PDate:
15.5.2006Country:
US
Number:
637520Date:
12.12.2006Country:
US
Classification
Categories:
A61K 31/70, C07H 19/00, C07H 19/04, C07H 21/00, A61P 31/20
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 18.11.2016
Expires: 12.12.2017
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 19.12.2017
Expires: 12.12.2018
Payer: Sigurjónsson & Thor ehf.
Number: 13
Paid: 20.11.2018
Expires: 12.12.2019
Payer: Sigurjónsson & Thor ehf.
Number: 14
Paid: 5.12.2019
Expires: 12.12.2020
Payer: Sigurjónsson & Thor ehf.